Virtual Library
Start Your Search
E.E. Nguyen
Author of
-
+
P3.10 - Nursing/Palliative Care/Ethics (ID 726)
- Event: WCLC 2017
- Type: Poster Session with Presenters Present
- Track: Nursing/Palliative Care/Ethics
- Presentations: 1
- Moderators:
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.10-004 - Immunotherapy: Emergency Department Provider Needs Assessment Survey (ID 10359)
09:30 - 09:30 | Author(s): E.E. Nguyen
- Abstract
Background:
Globally, lung cancer is the second most common cancer diagnosis and the leading cause of cancer death (WHO, 2017). Over the last decade, many efforts have focused on lung cancer prevention, early diagnosis, and finding more effective treatments. In the last two years, the FDA approved of a new class of medications called checkpoint inhibitors or immunotherapy, with proven efficacy in treating advanced lung cancer and several other malignancies. These drugs incite the immune system, resulting in unique immune-related adverse events (irAEs) which are difficult to diagnose, challenging to manage, and potentially life threatening if not properly assessed and managed. Diagnosis of irAEs are typically made on exclusion. It is vital that the medical team and supportive services have current and accurate knowledge on these therapies when patients present for work up during flare-ups.
Method:
A needs assessment survey was given to St. Joseph Hospital Emergency Care Center (ECC) providers and Registered Nurses at a department staff meeting. A one page pre in-service survey was administered in English only, followed a brief in-service, and a post in-service survey immediately followed. The Pre and post survey was used to evaluate effectiveness of teaching. Sample size: 20 MD’s or PA’s and 65 NP’s or RN’s. Selected questions assisted in identifying knowledge deficits among St Joseph Hospital ECC physicians and registered nurses. We were able to evaluate the effectiveness of teaching, and obtained feedback on the value of implementing an immunotherapy patient identification card. Knowledge of immunotherapy side effect management was measured with an identical pre and post in-service survey. The survey contained 5 items that measured the individual’s current knowledge/comfort with managing immunotherapy side effects for oncology patients receiving immunotherapy who are evaluated in St. Joseph Hospital Emergency Department. The questions were developed in conjunction with our current and prior Thoracic Oncology Program Medical Directors.
Result:
Data was analyzed with the Wilcoxon Statistic Responses. We identified a significant knowledge gap by our ECC providers at our institution. These providers are often the first to assess irAEs when patients present to the hospital with significant medical issues. Teaching intervention was effective as evidenced by post test results.
Conclusion:
IrAEs is a vital and relevant topic for our patient populations. ECC providers and our multidisciplinary providers are supportive of introducing Immuno-Oncology patient wallet cards and further education on Immunotherapy. Future projects include implementation of ISLAC’s irAEs management guidelines.
